Overview
Diskets is approved by the U.S. Food and Drug Administration (FDA) for the detoxification and maintenance treatment of opioid addiction, including addiction to heroin or other morphine-like drugs. It is intended to be used as part of a certified opioid treatment program along with appropriate social and medical services. Diskets is also known by its drug name, methadone hydrochloride.

Diskets belongs to the opioid agonist drug category. It works by activating opioid receptors in the brain to reduce withdrawal symptoms and opioid cravings, helping to stabilize people and prevent relapse to illicit opioid use.

How do I take it?
Prescribing information states that Diskets is taken orally (by mouth) as dispersible tablets that must be dissolved in liquid before being taken. Initial detoxification treatment often begins with a single dose sufficient to suppress withdrawal symptoms. Daily maintenance treatment dose sizes vary from person to person. The dose and schedule should be followed exactly as prescribed by a healthcare provider, and abrupt discontinuation should be avoided in people who are physically dependent patients.

Side effects
Common side effects of Diskets include lightheadedness, dizziness, sedation, nausea, vomiting, and sweating.

Rare but serious side effects may include life-threatening respiratory depression (especially during dose initiation or increase), QT interval prolongation leading to serious heart arrhythmias (torsades de pointes), serotonin syndrome (a potentially fatal reaction caused by certain drug combinations), adrenal insufficiency (impaired hormone production by adrenal glands), severe low blood pressure, neonatal opioid withdrawal syndrome in newborns from opioid-exposed pregnancies, and increased risk of overdose. Accidental ingestion, especially by children, can be fatal.

For more information about this treatment, visit:
Label: Diskets — Methadone Hydrochloride Tablet — DailyMed